Thailand’s Decision to Manufacture Generic AIDS Drug Wins Acclaim

by Medindia Content Team on  December 1, 2006 at 7:19 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Thailand’s Decision to Manufacture Generic AIDS Drug Wins Acclaim
In the wake of escalating costs of second-line HIV-AIDS drugs, Thailand has allowed, for the first time, the manufacture of the cost effective version of the drug 'Efavirenz', which has been a boon to many sufferers.

Merck & Co Inc, the patent holder of the drug has opposed the decision of the government to issue a five year license, allowing the manufacture and import of the drug, also termed, Stocrin. But this move has been seconded by AIDS activists and health experts.

"This is both a brave and a progressive step by the Royal Thai Government to place the interests of people living with HIV in Thailand front and centre," UNAIDS country coordinator Patrick Brenny said



Source: Medindia
SAV

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs AIDS - Initial Theories and Disease Progression 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive